MRK Merck
$128.58 +0.16%
US Stock · Healthcare
RSI (14) · 30 / 70 bands
MACD (12, 26, 9)
Solid = close · dashed = 50-day MA · bars = volume. Toggle Bollinger / RSI / MACD. Hover to inspect. EOD data.
1D
+0.16%
YTD
+59.40%
P/E
99.36
P/B
4.97
ROE
17.9%
Div yield
2.6%
Beta
0.11
Market cap
$315.3B
RSI (14)
65
Next earnings
Oct 29, 2026
Previous session
close of Aug 7, 2026 · EOD, no live order bookOpen
$127.84
Close
$128.58
VWAP (n/a)
—
Day high
$128.75
Day low
$126.68
Volume
5.1M
VWAP = daily turnover ÷ volume — the volume-weighted average, the closest EOD read on where trading actually clustered. A true order book is live-only and needs a broker feed. Turnover/VWAP available for MOEX listings.
Latest headlines
Merck (MRK) Could Be 3% Undervalued On Raised Outlook And Key Drug Approvals
Yahoo Finance · Aug 7
This Biotech Dealmaker — Tied To Merck, Travere — Is In A Profit-Taking Zone
Yahoo Finance · Aug 6
Merck & Co’s Stock: Analyst Estimates & Ratings
Yahoo Finance · Aug 6
Endometrial Cancer Market Share Analysis and Industry Trends (2026-2031) Featuring Merck, Eisai, Karyopharm Therapeutics, Context Therapeutics, Seagen and More
Yahoo Finance · Aug 7
After Q2 Earnings, Is Pfizer or Merck the Smarter Dividend Play?
Yahoo Finance · Aug 6
MSD and Gilead scrap Phase III Trodelvy-Keytruda study on lacklustre interim data
Yahoo Finance · Aug 6
Headlines via Yahoo Finance · links open the source · not an endorsement.
Recent SEC filings
10-Q Aug 7, 2026 View → 8-K Aug 4, 2026 View → 8-K May 28, 2026 View → 8-K May 22, 2026 View → 10-Q May 4, 2026 View →
Source: SEC EDGAR · opens the official filing.
Research & reports
External resources — availability and opinions are theirs, not ours.
This is reference data for your own analysis — not a recommendation to buy or sell MRK. Try it in the Lab to size a position and see the risk.